Ratio Therapeutics raised $50M Series B venture round, led by Duquesne.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
DuquesneLEAD | Venture Capital | — |
SchustermanLEAD | Venture Capital | — |
| Venture Capital | — |
| Public | — |
| University Fund | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$70M
Top Valuation
-
Ratio Therapeutics raised $50M in a Series B round.
The round was announced on 01/18/24.
The round was led by Duquesne, Schusterman.